Scholars Central

Conference abstractPublished 23 Jul 2018

The dysfunction of Na/K pump α subunit as the principal cause for carcinogenesis and target of the effect of cisplatin

Authors: Liana Yeganyan, Yerazik Mikayelyan, Emma Ayvazyan, Gagik Bazikyan, Sinerik Ayrapetyan

Life Sciences International Postgraduate Educational Center, Armenia National Center of Oncology, Armenia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The aim of the present research is to find out the functional differences and individual roles of Ã?±1, Ã?±2, Ã?±3 isoforms of Ã?± subunit of Na/K pump in normal and cancer cell membranes, and to establish the role of hydration in these processes. Hydration of some tissues (heart muscle, skeletal muscle, tissues removed from lung, liver, spleen, kidney, sarcoma-180) of healthy and sarcoma-180 carrying exogamic male albinos mice have been measured and compared. The data allow us to consider the change of cell hydration as an extra sensitive universal diagnostic parameter for cell pathology. It was shown that, Ã?±3-isoform dependent intracellular signaling system controlling cell hydration in excitable and non-excitable tissues have different nature. It means that the functional status of Ã?±3 isoform of Na/K pump can be an important component in the process of the development of cancer. The effect of cisplatin on tissue hydration of some tissues (heart muscle, skeletal muscle, tissues removed from lung, liver, spleen, kidney, sarcoma-180) of healthy and sarcoma-180 carrying mice was investigated. The effect of cisplatin on 3H-ouabain binding with Ã?±1, Ã?±2 and Ã?±3 isoforms of Ã?± subunit of Na/K pump is also determined. It was found that cisplatin increases the affinity of Ã?±3 subunit toward ouabain. Together with other intracellular components the Ã?±3 isoform of Ã?± subunit is also a target for cisplatin. These investigations give us the opportunity for the development and introduction of new methods to prevent and to give the early diagnosis of cancer, as well as to decrease the side effects arising during chemotherapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Liana Yeganyan”
  • BylineArticles whose byline prints “Yerazik Mikayelyan”
  • BylineArticles whose byline prints “Emma Ayvazyan”
  • BylineArticles whose byline prints “Gagik Bazikyan”
  • BylineArticles whose byline prints “Sinerik Ayrapetyan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels